{"pmid":32440663,"title":"Pulmonary Thromboembolism as a Potential Cause of Clinical Deterioration in COVID-19 Patients; a Commentary.","text":["Pulmonary Thromboembolism as a Potential Cause of Clinical Deterioration in COVID-19 Patients; a Commentary.","Although the findings of some studies have been indicative of the direct relationship between the severity of clinical findings and imaging, reports have been published regarding inconsistency of clinical findings with imaging and laboratory evidence. Physicians treating these patients frequently report cases in which patients, sometimes in the recovery phase and despite improvements in imaging indices, suddenly deteriorate and in some instances suddenly expire. This letter aimed to draw attention to the role of pulmonary thromboembolism as a potential and possible cause of clinical deterioration in covid-19 patients.","Arch Acad Emerg Med","Safari, Saeed","Mehrani, Mehdi","Yousefifard, Mahmoud","32440663"],"abstract":["Although the findings of some studies have been indicative of the direct relationship between the severity of clinical findings and imaging, reports have been published regarding inconsistency of clinical findings with imaging and laboratory evidence. Physicians treating these patients frequently report cases in which patients, sometimes in the recovery phase and despite improvements in imaging indices, suddenly deteriorate and in some instances suddenly expire. This letter aimed to draw attention to the role of pulmonary thromboembolism as a potential and possible cause of clinical deterioration in covid-19 patients."],"journal":"Arch Acad Emerg Med","authors":["Safari, Saeed","Mehrani, Mehdi","Yousefifard, Mahmoud"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32440663","source":"PubMed","week":"202021|May 18 - May 24","keywords":["covid-19","clinical deterioration","computed tomography angiography","embolism and thrombosis","platelet aggregation inhibitors"],"weight":0,"_version_":1667523504839327745,"score":9.490897,"similar":[{"pmid":32386804,"title":"Imaging & other potential predictors of deterioration in COVID-19.","text":["Imaging & other potential predictors of deterioration in COVID-19.","This case report describes a young patient with COVID-19 who is initially diagnosed with CT chest imaging. Upon admission to the hospital, his clinical condition deteriorates requiring ventilatory support. We explore the value of imaging and other potential predictors of deterioration.","Am J Emerg Med","Shah, Kaushal","Kamler, Jonathan","Phan, Alexander","Toy, Dennis","32386804"],"abstract":["This case report describes a young patient with COVID-19 who is initially diagnosed with CT chest imaging. Upon admission to the hospital, his clinical condition deteriorates requiring ventilatory support. We explore the value of imaging and other potential predictors of deterioration."],"journal":"Am J Emerg Med","authors":["Shah, Kaushal","Kamler, Jonathan","Phan, Alexander","Toy, Dennis"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32386804","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.ajem.2020.04.075","keywords":["covid-19","chest computed tomography","imaging","pneumonia","risk factors"],"topics":["Case Report"],"weight":1,"_version_":1666428892686057474,"score":167.71313},{"pmid":32443899,"title":"Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy.","text":["Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy.","We described features of hospitalized Covid-19 patients and identified predictors of clinical deterioration. We included patients consecutively admitted at Humanitas Research Hospital (Rozzano, Milan, Italy); retrospectively extracted demographic; clinical; laboratory and imaging findings at admission; used survival methods to identify factors associated with clinical deterioration (defined as intensive care unit (ICU) transfer or death), and developed a prognostic index. Overall; we analyzed 239 patients (29.3% females) with a mean age of 63.9 (standard deviation [SD]; 14.0) years. Clinical deterioration occurred in 70 patients (29.3%), including 41 (17.2%) ICU transfers and 36 (15.1%) deaths. The most common symptoms and signs at admission were cough (77.8%) and elevated respiratory rate (34.1%), while 66.5% of patients had at least one coexisting medical condition. Imaging frequently revealed ground-glass opacity (68.9%) and consolidation (23.8%). Age; increased respiratory rate; abnormal blood gas parameters and imaging findings; coexisting coronary heart disease; leukocytosis; lymphocytopenia; and several laboratory parameters (elevated procalcitonin; interleukin-6; serum ferritin; C-reactive protein; aspartate aminotransferase; lactate dehydrogenase; creatinine; fibrinogen; troponin-I; and D-dimer) were significant predictors of clinical deterioration. We suggested a prognostic index to assist risk-stratification (C-statistic; 0.845; 95% CI; 0.8020.887). These results could aid early identification and management of patients at risk, who should therefore receive additional monitoring and aggressive supportive care.","J Clin Med","Cecconi, Maurizio","Piovani, Daniele","Brunetta, Enrico","Aghemo, Alessio","Greco, Massimiliano","Ciccarelli, Michele","Angelini, Claudio","Voza, Antonio","Omodei, Paolo","Vespa, Edoardo","Pugliese, Nicola","Parigi, Tommaso Lorenzo","Folci, Marco","Danese, Silvio","Bonovas, Stefanos","32443899"],"abstract":["We described features of hospitalized Covid-19 patients and identified predictors of clinical deterioration. We included patients consecutively admitted at Humanitas Research Hospital (Rozzano, Milan, Italy); retrospectively extracted demographic; clinical; laboratory and imaging findings at admission; used survival methods to identify factors associated with clinical deterioration (defined as intensive care unit (ICU) transfer or death), and developed a prognostic index. Overall; we analyzed 239 patients (29.3% females) with a mean age of 63.9 (standard deviation [SD]; 14.0) years. Clinical deterioration occurred in 70 patients (29.3%), including 41 (17.2%) ICU transfers and 36 (15.1%) deaths. The most common symptoms and signs at admission were cough (77.8%) and elevated respiratory rate (34.1%), while 66.5% of patients had at least one coexisting medical condition. Imaging frequently revealed ground-glass opacity (68.9%) and consolidation (23.8%). Age; increased respiratory rate; abnormal blood gas parameters and imaging findings; coexisting coronary heart disease; leukocytosis; lymphocytopenia; and several laboratory parameters (elevated procalcitonin; interleukin-6; serum ferritin; C-reactive protein; aspartate aminotransferase; lactate dehydrogenase; creatinine; fibrinogen; troponin-I; and D-dimer) were significant predictors of clinical deterioration. We suggested a prognostic index to assist risk-stratification (C-statistic; 0.845; 95% CI; 0.8020.887). These results could aid early identification and management of patients at risk, who should therefore receive additional monitoring and aggressive supportive care."],"journal":"J Clin Med","authors":["Cecconi, Maurizio","Piovani, Daniele","Brunetta, Enrico","Aghemo, Alessio","Greco, Massimiliano","Ciccarelli, Michele","Angelini, Claudio","Voza, Antonio","Omodei, Paolo","Vespa, Edoardo","Pugliese, Nicola","Parigi, Tommaso Lorenzo","Folci, Marco","Danese, Silvio","Bonovas, Stefanos"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32443899","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.3390/jcm9051548","keywords":["2019 novel coronavirus","2019-ncov","covid-19","sars-cov-2","severe acute respiratory syndrome coronavirus 2"],"locations":["Rozzano","Milan","Italy","lymphocytopenia","Lombardy","Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"e_drugs":["Creatinine"],"topics":["Diagnosis"],"weight":1,"_version_":1667600475953823744,"score":160.35484},{"pmid":32463186,"title":"Pulmonary embolism in cases of COVID-19.","text":["Pulmonary embolism in cases of COVID-19.","BACKGROUND: Emerging reports indicate a high incidence of venous thromboembolism in patients hospitalised for SARS-CoV-2 pneumonia during the spring 2020 pandemic. The pronounced pulmonary and systemic inflammatory responses observed in these patients may contribute to a transient hypercoagulable state. In this setting, pulmonary embolism may cause further respiratory distress and clinical deterioration. CASE PRESENTATION: We describe the clinical course of three patients admitted with SARS-CoV-2 infection and respiratory distress, where pulmonary embolism was detected during the course of the hospitalisation. Two of the cases occurred despite early institution of standard dosage of low molecular weight heparin thromboprophylaxis, and in one case, pulmonary embolism was diagnosed during the convalescent phase of an otherwise benign COVID-19 disease course. INTERPRETATION: These cases highlight the importance of awareness of the potentially increased incidence of venous thromboembolism in COVID-19 disease. Further research is required to establish appropriate clinical management guidelines for prevention of thromboembolic complications in COVID-19.","Tidsskr Nor Laegeforen","Tveita, Anders","Hestenes, Siv","Sporastoyl, Eirik Robsahm","Pettersen, Stian Aleksander","Neple, Bente Lund","Myrstad, Marius","Tveit, Arnljot","Froen, Hege","Svendsen, Jan","Ronning, Else Johanne","32463186"],"abstract":["BACKGROUND: Emerging reports indicate a high incidence of venous thromboembolism in patients hospitalised for SARS-CoV-2 pneumonia during the spring 2020 pandemic. The pronounced pulmonary and systemic inflammatory responses observed in these patients may contribute to a transient hypercoagulable state. In this setting, pulmonary embolism may cause further respiratory distress and clinical deterioration. CASE PRESENTATION: We describe the clinical course of three patients admitted with SARS-CoV-2 infection and respiratory distress, where pulmonary embolism was detected during the course of the hospitalisation. Two of the cases occurred despite early institution of standard dosage of low molecular weight heparin thromboprophylaxis, and in one case, pulmonary embolism was diagnosed during the convalescent phase of an otherwise benign COVID-19 disease course. INTERPRETATION: These cases highlight the importance of awareness of the potentially increased incidence of venous thromboembolism in COVID-19 disease. Further research is required to establish appropriate clinical management guidelines for prevention of thromboembolic complications in COVID-19."],"journal":"Tidsskr Nor Laegeforen","authors":["Tveita, Anders","Hestenes, Siv","Sporastoyl, Eirik Robsahm","Pettersen, Stian Aleksander","Neple, Bente Lund","Myrstad, Marius","Tveit, Arnljot","Froen, Hege","Svendsen, Jan","Ronning, Else Johanne"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32463186","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.4045/tidsskr.20.0366","e_drugs":["Heparin, Low-Molecular-Weight"],"topics":["Case Report"],"weight":1,"_version_":1668079521213972481,"score":144.39311},{"pmid":32283217,"pmcid":"PMC7151464","title":"Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings.","text":["Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings.","This report highlights details on a pregnant case of COVID-19 who unfortunately did not survive. This 27-year-old woman at her 30 and 3/7 weeks' gestation was referred to our center with fever, myalgia, and cough. The laboratory investigations showed leukopenia and lymphopenia as well as increased creatinine and CRP levels. The first chest X-ray (faint bilateral patchy opacities) and CT scan (some faint subpleural ground-glass opacities associated with pleural thickening) were not typical for initial COVID-19 pulmonary infection, however, the treatment for COVID-19 was started. Due to respiratory distress, she was intubated and put under mechanical ventilation. After a while, the fetus was born with Apgar score of 0 and did not react to the neonatal cardiopulmonary resuscitation protocol. Finally, due to deterioration in the clinical and imaging findings, the patient was expired as a result of multi-organ failure. Following the death, autopsy was performed and the histopathologic evaluations of the lungs showed evidence of viral pneumonia (viral cytopathic effect and a mild increase in alveolar wall thickness) and ARDS (hyaline membrane). Also, reverse transcription-polymerase chain reaction (RT-PCR) confirmed SARS-CoV-2 infection in the lungs. To our knowledge, this is the first report of maternal death with confirmed COVID-19 infection.","Travel Med Infect Dis","Karami, Parisa","Naghavi, Maliheh","Feyzi, Abdolamir","Aghamohammadi, Mehdi","Novin, Mohammad Sadegh","Mobaien, Ahmadreza","Qorbanisani, Mohamad","Karami, Aida","Norooznezhad, Amir Hossein","32283217"],"abstract":["This report highlights details on a pregnant case of COVID-19 who unfortunately did not survive. This 27-year-old woman at her 30 and 3/7 weeks' gestation was referred to our center with fever, myalgia, and cough. The laboratory investigations showed leukopenia and lymphopenia as well as increased creatinine and CRP levels. The first chest X-ray (faint bilateral patchy opacities) and CT scan (some faint subpleural ground-glass opacities associated with pleural thickening) were not typical for initial COVID-19 pulmonary infection, however, the treatment for COVID-19 was started. Due to respiratory distress, she was intubated and put under mechanical ventilation. After a while, the fetus was born with Apgar score of 0 and did not react to the neonatal cardiopulmonary resuscitation protocol. Finally, due to deterioration in the clinical and imaging findings, the patient was expired as a result of multi-organ failure. Following the death, autopsy was performed and the histopathologic evaluations of the lungs showed evidence of viral pneumonia (viral cytopathic effect and a mild increase in alveolar wall thickness) and ARDS (hyaline membrane). Also, reverse transcription-polymerase chain reaction (RT-PCR) confirmed SARS-CoV-2 infection in the lungs. To our knowledge, this is the first report of maternal death with confirmed COVID-19 infection."],"journal":"Travel Med Infect Dis","authors":["Karami, Parisa","Naghavi, Maliheh","Feyzi, Abdolamir","Aghamohammadi, Mehdi","Novin, Mohammad Sadegh","Mobaien, Ahmadreza","Qorbanisani, Mohamad","Karami, Aida","Norooznezhad, Amir Hossein"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32283217","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.tmaid.2020.101665","keywords":["acute kidney injury","acute respiratory distress syndrome","coronavirus disease 2019","intrauterine fetal death","pregnancy","sars-cov-2"],"locations":["fever","myalgia"],"e_drugs":["Creatinine"],"topics":["Case Report"],"weight":1,"_version_":1666138491472314368,"score":130.97905},{"pmid":32320517,"title":"High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients.","text":["High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients.","BACKGROUND: Coagulopathy is a common abnormality in patients with COVID-19. However, the exact incidence of venous thromboembolic event is unknown in anticoagulated severe COVID-19 patients. OBJECTIVES: Systematic assessment of VTE using complete duplex ultrasound (CDU) in anticoagulated COVID-19 patients. PATIENTS AND METHODS: We performed a retrospective study in 2 French intensive care units (ICU) were CDU is performed as a standard of care. A CDU from thigh to ankle at selected sites with Doppler waveforms and images was performed early during ICU stay in patients admitted with COVID-19. Anticoagulation dose was left to the discretion of the treating physician based on the individual risk of thrombosis. Patients were classified as treated with prophylactic anticoagulation or therapeutic anticoagulation. Pulmonary embolism was systematically searched in patients with persistent hypoxemia or secondary deterioration. RESULTS: From March 19(th) to April 11(th) of 2020, 26 consecutive patients with severe COVID-19 were screened for VTE. 8 patients (31%) were treated with prophylactic anticoagulation whereas 18 patients (69%) were treated with therapeutic anticoagulation. The overall rate of VTE in patients was 69%. The proportion of VTE was significantly higher in patients treated with prophylactic anticoagulation when compared to the other group (100% vs. 56%, respectively, p=0.03). Surprisingly, we found a high rate of thromboembolic events in COVID-19 patients treated with therapeutic anticoagulation, with 56% of VTE and 6 pulmonary embolisms. CONCLUSION: Our results suggest considering both systematic screening of VTE and early therapeutic anticoagulation in severe ICU COVID-19 patients.","J Thromb Haemost","Llitjos, Jean-Francois","Leclerc, Maxime","Chochois, Camille","Monsallier, Jean-Michel","Ramakers, Michel","Auvray, Malika","Merouani, Karim","32320517"],"abstract":["BACKGROUND: Coagulopathy is a common abnormality in patients with COVID-19. However, the exact incidence of venous thromboembolic event is unknown in anticoagulated severe COVID-19 patients. OBJECTIVES: Systematic assessment of VTE using complete duplex ultrasound (CDU) in anticoagulated COVID-19 patients. PATIENTS AND METHODS: We performed a retrospective study in 2 French intensive care units (ICU) were CDU is performed as a standard of care. A CDU from thigh to ankle at selected sites with Doppler waveforms and images was performed early during ICU stay in patients admitted with COVID-19. Anticoagulation dose was left to the discretion of the treating physician based on the individual risk of thrombosis. Patients were classified as treated with prophylactic anticoagulation or therapeutic anticoagulation. Pulmonary embolism was systematically searched in patients with persistent hypoxemia or secondary deterioration. RESULTS: From March 19(th) to April 11(th) of 2020, 26 consecutive patients with severe COVID-19 were screened for VTE. 8 patients (31%) were treated with prophylactic anticoagulation whereas 18 patients (69%) were treated with therapeutic anticoagulation. The overall rate of VTE in patients was 69%. The proportion of VTE was significantly higher in patients treated with prophylactic anticoagulation when compared to the other group (100% vs. 56%, respectively, p=0.03). Surprisingly, we found a high rate of thromboembolic events in COVID-19 patients treated with therapeutic anticoagulation, with 56% of VTE and 6 pulmonary embolisms. CONCLUSION: Our results suggest considering both systematic screening of VTE and early therapeutic anticoagulation in severe ICU COVID-19 patients."],"journal":"J Thromb Haemost","authors":["Llitjos, Jean-Francois","Leclerc, Maxime","Chochois, Camille","Monsallier, Jean-Michel","Ramakers, Michel","Auvray, Malika","Merouani, Karim"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32320517","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jth.14869","keywords":["covid-19","sars-cov-2","anticoagulation","critical care","pulmonary embolism","venous thromboembolism"],"locations":["French"],"countries":["France"],"countries_codes":["FRA|France"],"topics":["Treatment"],"weight":1,"_version_":1666138493731995648,"score":126.39718}]}